Alzheimer's disease begins with a long period during which abnormal amyloid and tau proteins build up in the brain without ...
As the second oral therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of Alzheimer’s disease during the past decade, ZUNVEYL demonstrates a potentially better safety ...
Revised guidelines for amyloid and tau positron emission tomography for Alzheimer’s disease and dementia state these tests ...
Dementia drivers license loophole sparks safety concerns in South Korea Koreas lack of legal measures puts dementia patients ...
Family urges action as Korean driver with dementia causes fatal crash Seoul lacks regulations on halting driving for dementia ...
Consistent with the approach taken by other alternative payment models, GUIDE frames the emergency department as a negative ...
A simple digital health tool developed by Australian researchers could soon help predict the age of onset for early Alzheimer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback